Results per Page:
Liver-humanized mice to study hepatis B virus infection
From the Jerome lab, Vaccine and Infectious Disease Division
CMV breakthrough and resistance to antiviral drug after blood stem cell transplants
From Dr. Danniel Zamora and the Boeckh Group, Vaccine and Infectious Disease Division
Antivirals have untapped potential in reducing SARS-CoV-2 related deaths
From the Brown and Janes labs, Public Health Sciences and Vaccine and Infectious Disease Divisions
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
Experts from leading cancer centers ask, ‘Where’s the outcry?’
Antiviral drug for post-transplant complications now costs more than the transplant